Stock TTALO TERVEYSTALO OYJ
Add to a list
To use this feature you must be a member
Log inSign up

Financials Terveystalo Oyj

Equities

TTALO

FI4000252127

Healthcare Facilities & Services

Market Closed - Nasdaq Helsinki
Other stock markets
 09:30:00 25/06/2024 pm IST 		5-day change 1st Jan Change
8.7 EUR -2.79% Intraday chart for Terveystalo Oyj -2.90% +12.40%
30/05 Terveystalo Plc Appoints Petra Gräsbeck as SVP, Communications and Public Affairs and Member of the Executive Team CI
26/04 Transcript : Terveystalo Oyj, Q1 2024 Earnings Call, Apr 26, 2024

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,423 1,278 1,495 790.9 979.5 1,101 - -
Enterprise Value (EV) 1 1,971 1,769 2,014 1,358 1,578 1,630 1,564 1,549
P/E ratio 26 x 27.9 x 18.8 x 32.9 x -23.5 x 15.9 x 12.4 x 11.1 x
Yield 2.33% 1.29% 2.36% 4.48% 3.88% 3.79% 4.14% 4.48%
Capitalization / Revenue 1.38 x 1.3 x 1.3 x 0.63 x 0.76 x 0.83 x 0.8 x 0.77 x
EV / Revenue 1.91 x 1.79 x 1.74 x 1.08 x 1.23 x 1.23 x 1.14 x 1.08 x
EV / EBITDA 11.2 x 10.9 x 9.77 x 7.63 x 7.88 x 7.39 x 6.58 x 6.27 x
EV / FCF 14.1 x 16 x 13.2 x 16.6 x 13.5 x 13.2 x 11.3 x 10.8 x
FCF Yield 7.1% 6.25% 7.55% 6.02% 7.42% 7.55% 8.86% 9.27%
Price to Book 2.64 x 2.25 x 2.49 x 1.33 x 1.9 x 2 x 1.84 x 1.7 x
Nbr of stocks (in thousands) 1,27,307 1,27,307 1,26,307 1,26,548 1,26,556 1,26,556 - -
Reference price 2 11.18 10.04 11.84 6.250 7.740 8.700 8.700 8.700
Announcement Date 13/02/20 11/02/21 10/02/22 10/02/23 14/02/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,031 986.4 1,155 1,259 1,286 1,329 1,377 1,429
EBITDA 1 176.3 162.8 206.1 178 200.2 220.5 237.7 247.1
EBIT 1 86.5 71.6 114.4 33.9 -14.7 114.3 135.9 146.6
Operating Margin 8.39% 7.26% 9.91% 2.69% -1.14% 8.6% 9.87% 10.26%
Earnings before Tax (EBT) 1 66.8 56.6 100.7 30.9 -38.9 87.76 112 125.9
Net income 1 54.1 45.8 80.5 24.4 -42.2 69.54 88.98 99.9
Net margin 5.25% 4.64% 6.97% 1.94% -3.28% 5.23% 6.46% 6.99%
EPS 2 0.4300 0.3600 0.6300 0.1900 -0.3300 0.5459 0.7008 0.7870
Free Cash Flow 1 140 110.6 152.1 81.7 117 123.1 138.5 143.7
FCF margin 13.58% 11.21% 13.17% 6.49% 9.1% 9.27% 10.06% 10.05%
FCF Conversion (EBITDA) 79.41% 67.94% 73.8% 45.9% 58.44% 55.85% 58.28% 58.13%
FCF Conversion (Net income) 258.78% 241.48% 188.94% 334.84% - 177.06% 155.69% 143.81%
Dividend per Share 2 0.2600 0.1300 0.2800 0.2800 0.3000 0.3300 0.3600 0.3900
Announcement Date 13/02/20 11/02/21 10/02/22 10/02/23 14/02/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 327.5 329.7 318.2 276.4 334.8 341.1 322.4 280.5 342.4 350.2 332.4 291 356.3
EBITDA 1 59.1 56.6 42.4 30.9 48 55.3 47.1 39.7 58.1 65.7 51.8 44.5 62.67
EBIT 1 34.8 31.2 14.6 -24.6 12.8 19.1 15 10.2 -58.9 35.7 24.87 17.83 35.9
Operating Margin 10.63% 9.46% 4.59% -8.9% 3.82% 5.6% 4.65% 3.64% -17.2% 10.19% 7.48% 6.13% 10.08%
Earnings before Tax (EBT) 1 31.8 31.3 14.1 -24.3 9.8 14.1 9.8 3.6 -66.4 29.6 18.1 11.1 29.3
Net income 1 25.8 24.9 11.1 -19.6 7.6 11.1 7.5 3.3 -64.1 23.6 13.8 8 23.47
Net margin 7.88% 7.55% 3.49% -7.09% 2.27% 3.25% 2.33% 1.18% -18.72% 6.74% 4.15% 2.75% 6.59%
EPS 2 0.2000 0.2000 0.0900 -0.1500 0.0600 0.0900 0.0600 0.0300 -0.5100 0.1900 0.1133 0.0667 0.1850
Dividend per Share - - - - - - - - 0.3000 - - - -
Announcement Date 10/02/22 28/04/22 19/07/22 27/10/22 10/02/23 28/04/23 18/07/23 27/10/23 14/02/24 26/04/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 548 491 519 567 598 529 463 448
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.109 x 3.015 x 2.518 x 3.183 x 2.988 x 2.4 x 1.947 x 1.813 x
Free Cash Flow 1 140 111 152 81.7 117 123 139 144
ROE (net income / shareholders' equity) 10.3% 8.23% 13.6% 4.1% 11.8% 13.4% 15.6% 16.4%
ROA (Net income/ Total Assets) 4.3% 3.37% 5.73% 1.67% -2.91% 5% 6.32% 6.86%
Assets 1 1,258 1,360 1,405 1,464 1,449 1,392 1,407 1,457
Book Value Per Share 2 4.230 4.460 4.760 4.700 4.070 4.340 4.720 5.110
Cash Flow per Share 2 1.360 1.130 1.530 1.110 1.250 1.520 1.590 1.600
Capex 1 33.6 33.1 43.1 59.2 41 36.5 39.2 50.1
Capex / Sales 3.26% 3.36% 3.73% 4.7% 3.19% 2.75% 2.85% 3.51%
Announcement Date 13/02/20 11/02/21 10/02/22 10/02/23 14/02/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Terveystalo Oyj

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
8.7 EUR
Average target price
10 EUR
Spread / Average Target
+14.94%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
TERVEYSTALO OYJ Stock Terveystalo Oyj
+12.40% 1.18B
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-32.87% 13.37B
IHH HEALTHCARE Stock IHH Healthcare
+4.15% 11.75B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
-3.60% 11.57B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+8.89% 10.85B
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+27.20% 8.55B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-11.80% 7.24B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+7.99% 6.84B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+9.12% 6.5B
FORTIS HEALTHCARE LIMITED Stock Fortis Healthcare Limited
+15.47% 4.39B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. TTALO Stock
  4. Financials Terveystalo Oyj